Activity Chair:
Eric S. Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Torrance, CA
Co-Chair:
Anne Monroe, MD, MSPH
Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Faculty:
Richard A. Elion, MD
Associate Clinical Professor of Medicine
George Washington University School of Medicine
Co-Director, DC Dept of Health STD Research Program
Washington, DC
Kathleen E. Squires, MD
W. Paul and Ida H. Havens Professor of Infectious Diseases
Director, Division of Infectious Diseases
Sidney Kimmel Medical College of Thomas Jefferson University
Philadelphia, PA
Babafemi Taiwo, MBBS
Associate Professor in Medicine-Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, IL
Peer Reviewers:
Risha Irvin, MD
Jennifer Cocohoba, PharmD
Policy on Speaker and Provider Disclosure:
It is the policy of the Johns Hopkins University School of Medicine (and the Institute for Johns Hopkins Nursing) and Vindico Medical Education that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME and Vindico Medical Education have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.
Full Disclosure Policy Affecting CME Activities:
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) in collaboration with Vindico Medical Education, requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity provided by OCME. The following relationships have been reported for this activity:
Planning Committee and Faculty members report the following relationship(s):
Eric S. Daar, MD
Consulting Fees: (Paid to Institution) Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Teva, ViiV
Contracted Research: (Paid to Institution) Gilead, Merck, ViiV
Anne Monroe, MD, MSPH
No relevant financial relationships to disclose.
Richard A. Elion, MD
Speakers Bureau: Gilead Sciences, Jannsen, Merck, ViiV
Advisor: Gilead Sciences, Merck, ViiV
Expert Witness: Gilead Sciences
Kathleen E. Squires, MD
Contracted Research: (Paid to Institution) Gilead Sciences
Board Member: Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, ViiV
Babafemi Taiwo, MBBS
Consulting Fees: ViiV
Contracted Research: ViiV
Peer Reviewers reports the following relationship(s):
Risha Irvin, MD
No relevant financial relationships to disclose.
Jennifer Cocohoba, PharmD
No relevant financial relationships to disclose.
The Johns Hopkins University School of Medicine and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at The Johns Hopkins University School of Medicine.
Unlabeled and Investigational Usage:
No speaker has indicated that he/she will reference unlabeled/unapproved uses of drugs or products.
Johns Hopkins Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.